Primary liver tumors: origin and target therapy.

Area of Science:

• Hepatology
• Oncology
• Stem Cell Biology

Background:

• The liver, the body's largest gland, has remarkable regenerative capacity.
• Primary liver tumors present a growing global health concern due to rising incidence and mortality.
• Recent research investigates hepatocyte ancestors, focusing on their proliferative, differentiation, and self-renewal capabilities.

Purpose of the Study:

• To review the cellular origins of primary liver tumors.
• To explore the potential of stem cells in future liver cancer therapeutic strategies.

Main Methods:

• Literature review of relevant scientific publications.

Main Results:

• Hepatic progenitor cells (HPCs) are implicated as the origin for hepatocellular carcinomas (HCC), cholangiocarcinomas (CHC), hepatocellular adenomas, and hepatoblastomas.
• The cancer stem cell (CSC) theory highlights the crucial role of hepatic stem cells in liver tumor development and progression.

Conclusions:

• HPC markers show promise as independent prognostic factors for HCC.
• Current HCC treatments are often ineffective; novel approaches like gene and targeted drug therapy are of significant clinical interest.